The Journal of Experimental Medicine
R&D Systems
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents
Published online December 4, 2006
doi:10.1084/jem.20061640
The Journal of Experimental Medicine, Vol. 203, No. 13, 2817-2827
The Rockefeller University Press, 0022-1007 $30.00
© 2006 Berruyer et al.
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow PPT slides of all figures
Right arrow Alert me when this article is cited
Right arrow Citation Map
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new content in the JEM
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Berruyer, C.
Right arrow Articles by Galland, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Berruyer, C.
Right arrow Articles by Galland, F.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*Nucleotide
*Protein*UniGene
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*BISPHENOL A DIGLYCIDYL ETHER
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

ARTICLE

 Vanin-1 licenses inflammatory mediator production by gut epithelial cells and controls colitis by antagonizing peroxisome proliferator-activated receptor {gamma} activity

Carole Berruyer1,2,3, Laurent Pouyet1,2,3, Virginie Millet1,2,3, Florent M. Martin1,2,3, Aude LeGoffic1, Alexandra Canonici1, Stéphane Garcia4, Claude Bagnis5, Philippe Naquet1,2,3, and Franck Galland1,2,3

1 Centre d'Immunologie de Marseille-Luminy, Université de la Méditerranée, 13288 Marseille Cedex 9, France
2 Institut National de la Santé et de la Recherche Médicale (INSERM) U631, 13288 Marseille Cedex 9, France
3 Centre National de la Recherche Scientifique (CNRS) UMR6102, 13288 Marseille Cedex 9, France
4 Service d'Anatomie Pathologique, Faculté de Médecine Nord, 13915 Marseille Cedex 9, France
5 Etablissement Français du Sang Alpes Méditerranée, 13005 Marseille Cedex 9, France

CORRESPONDENCE Franck Galland: fgpn{at}ciml.univ-mrs.fr

Colitis involves immune cell–mediated tissue injuries, but the contribution of epithelial cells remains largely unclear. Vanin-1 is an epithelial ectoenzyme with a pantetheinase activity that provides cysteamine/cystamine to tissue. Using the 2,4,6-trinitrobenzene sulfonic acid (TNBS)-colitis model we show here that Vanin-1 deficiency protects from colitis. This protection is reversible by administration of cystamine or bisphenol A diglycidyl ether, a peroxisome proliferator-activated receptor (PPAR){gamma} antagonist. We further demonstrate that Vanin-1, by antagonizing PPAR{gamma}, licenses the production of inflammatory mediators by intestinal epithelial cells. We propose that Vanin-1 is an epithelial sensor of stress that exerts a dominant control over innate immune responses in tissue. Thus, the Vanin-1/pantetheinase activity might be a new target for therapeutic intervention in inflammatory bowel disease.

Abbreviations used: ATRA, all trans-retinoic acid; BADGE, bisphenol A diglycidyl ether; COX, cyclooxygenase; 15-d-PGJ2, 15-deoxy-{Delta}12,14-prostaglandin J2; GSH, glutathione; IBD, inflammatory bowel disease; IEC, intestinal epithelial cell; MCP, monocyte chemoattractant protein; MIP, macrophage inflammatory protein; PPAR, peroxisome proliferator-activated receptor; SCID, severe combined immunodeficient; TNBS, 2,4,6-trinitrobenzene sulfonic acid.

C. Berruyer's present address is National de la Santé et de la Recherche Médicale, U599 27, 13009 Marseille, France.

F.M. Martin's present address is The Scripps Research Institute, Department of Molecular and Experimental Medicine, MEM-131, La Jolla, CA 92037.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:



  Home | Help | Feedback | Subscriptions | Archive | Search
TABLE OF CONTENTS